Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same author

Prospective Single-Site Open-label Study Assessing Safety and Efficacy of Poly-L-Lactic Acid for Temple Volume Loss.

Journal of drugs in dermatology : JDD·2026
Same author

A Single-Center, Open-Label, Prospective Study of a 589/1319 nm Dual Wavelength Laser for the Treatment of Facial Hyperpigmentation.

Journal of drugs in dermatology : JDD·2024
Same author

A Clinical Histology Study Evaluating the Biostimulatory Activity Longevity of Injectable Poly-L-Lactic Acid for Facial Rejuvenation.

Journal of drugs in dermatology : JDD·2024
Same author

Combination therapy in female pattern hair loss.

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology·2023
Same author

Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations.

Plastic and reconstructive surgery. Global open·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 25, 2026

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

1.6K

Cheek augmentation with Dermicol-P35 27G.

Neil S Sadick1, Laura Palmisano

  • 1Sadick Dermatology, New York, NY 10075, USA. nssderm@sadickdermatology.com

Aesthetic Surgery Journal
|July 7, 2009
PubMed
Summary
This summary is machine-generated.

Cheek augmentation using Dermicol-P35, a novel porcine-based collagen filler, effectively restores facial volume and enhances contours. This treatment offers a 12-month persistence of results without requiring prior sensitivity testing.

More Related Videos

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.7K
Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses
10:45

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses

Published on: June 13, 2018

11.3K

Related Experiment Videos

Last Updated: Mar 25, 2026

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

1.6K
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.7K
Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses
10:45

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses

Published on: June 13, 2018

11.3K

Area of Science:

  • Aesthetic medicine and dermatology.
  • Biomaterials and tissue engineering.

Background:

  • Facial aging leads to volume loss and contour changes, impacting attractiveness.
  • Cheek augmentation aims to rejuvenate appearance, enhance prominence, and improve symmetry.

Observation:

  • A new porcine-based collagen filler, Dermicol-P35 (Evolence), is available.
  • This filler does not require pretreatment sensitivity testing.
  • Clinical trials show 12-month persistence of results.

Findings:

  • Dermicol-P35 effectively restores lost facial volume in cheek augmentation.
  • The filler enhances cheek prominence and improves facial symmetry.
  • Patient clinical experience with Dermicol-P35 is discussed.

Implications:

  • Dermicol-P35 offers a new option for non-surgical cheek augmentation.
  • The filler's ease of use (no sensitivity testing) may improve patient accessibility.
  • Long-lasting results contribute to sustained facial rejuvenation.